Filter posts

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led …

Jim Greenwood Shares his Thoughts on BIO India

As a non-profit trade association that represents the biotech industry, BIO is pleased to bring …

BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry

BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different …

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by …

Spotlight on India’s Emerging Biotech Sector

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with …

2012 BIO India International Conference: Top Five Reasons to Attend

The third annual BIO India International Conference will be held September 12-13 at the Grand …

Patent Evergreening in India: Response from the Other Side

Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in …

India Compulsory License: A Times of India Article Says It's Not Helping the Poor

India recently issued a compulsory license on Bayer’s liver and kidney cancer drug (Sorafenib) with …

Meet 2011's Buzz of BIO Winner, Amrita Therapeutics

2011 Buzz of BIO Health Winner Amrita Therapeutics is a bio-pharma discovery company based in …

Patent "Ever-Greening": Novartis Confronts Patent Myth in India

India’s ‘increased efficacy’ patentability requirement for medicines prevents an improved form of a known drug …